Mediator complex subunit 13-like (MED13L)

Mediator complex subunit 13-like (MED13L) is a protein encoded by the MED13L gene, and forms part of the kinase module of the Mediator complex—an evolutionarily conserved multi-protein assembly essential for transmitting signals from sequence-specific DNA-bound transcription factors to RNA polymerase II, thereby regulating gene transcription[1][3][6][7]. It operates as both a structural component and functional regulator, ensuring appropriate gene expression, cell cycle progression, and recruitment of chromatin modifiers. MED13L plays a critical developmental role in organogenesis, especially of the heart and brain, influencing cardiac morphogenesis, craniofacial development, and neuronal dendritic arborization[2][4][5]. Pathogenic variants in MED13L are associated with a clinically recognized intellectual disability syndrome (MED13L syndrome), which commonly includes developmental delay, intellectual disability, hypotonia, speech impairment, distinctive facial features, seizures, and congenital heart defects[1][2][3][4][5][7]. The protein does not serve as a direct therapeutic target (e.g., receptor, enzyme), but variations in its gene are important for clinical genetics and neurodevelopmental disease diagnostics. MED13L integrates the CDK8 kinase module into the core Mediator complex, which can repress gene transcription by preventing core Mediator and RNA polymerase II interactions. It orchestrates dissociation via proteasome-mediated degradation, facilitating dynamic transcriptional control[4]. Disease-associated missense or truncating variants impact protein structure, stability, localization (nuclear/cytoplasmic), and interaction with other Mediator components, contributing to clinical manifestations[4][5].

Other names

Mediator of RNA polymerase II transcription subunit 13-likeKIAA1025PROSIT240THRAP2TRAP240LThyroid hormone receptor-associated protein 2Thyroid hormone receptor-associated protein complex 240 kDa component-likeMRFACD